BTI
CSTL icon

Blue Trust Inc’s Castle Biosciences CSTL Stock Holding History

Blue Trust Inc’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-956
Closed -$20.8K – 2553
2024
Q3 		$20.8K Hold
956
– – ﹤0.01% 1924
2024
Q2 		$21.2K Hold
956
– – ﹤0.01% 1635
2024
Q1 		$21.2K Hold
956
– – ﹤0.01% 1208
2023
Q4 		$16K Hold
956
– – ﹤0.01% 1384
2023
Q3 		$13K Buy
+956
New +$16.7K ﹤0.01% 1317

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Blue Trust Inc's CSTL Position: Q4 2024 in Review

Blue Trust Inc sold out of Castle Biosciences (CSTL) in Q4 2024, closing a stake of 956 shares — an estimated $20.8K sold.

Blue Trust Inc first reported a position in CSTL in Q3 2023 and held it in 5 quarters. The position peaked at $21.2K in Q2 2024. 197 funds tracked by Wall St. Rank hold CSTL as of Q4 2024.

  • Blue Trust Inc reported no remaining Castle Biosciences position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 956 Castle Biosciences shares in Q4 2024, an estimated $20.8K.
  • Blue Trust Inc first reported a position in Castle Biosciences in Q3 2023 and held it in 5 quarters.
  • Blue Trust Inc's Castle Biosciences position peaked at $21.2K in Q2 2024.
  • 197 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.